The Prostate Specific Antigen (PSA) market is a segment of the Diagnostics industry that focuses on the detection of prostate cancer. PSA tests measure the amount of PSA in a patient's blood, which can be an indicator of prostate cancer. PSA tests are typically used in conjunction with other tests, such as digital rectal exams, to diagnose prostate cancer. PSA tests are also used to monitor the progression of prostate cancer in patients who have already been diagnosed. The PSA market is highly competitive, with a number of companies offering PSA tests. Some of the major players in the market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, and Beckman Coulter. Other companies in the market include Becton Dickinson, Ortho Clinical Diagnostics, and Sysmex Corporation. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
